Ubs Asset Management Americas Inc Rocket Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 119,633 shares of RCKT stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119,633
Previous 118,072
1.32%
Holding current value
$1.41 Million
Previous $2.54 Million
13.1%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$208 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$132 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$72.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$65.1 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$52.8 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $889M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...